EFG
ONCY

Everhart Financial Group’s Oncolytics Biotech ONCY Stock Holding History

Everhart Financial Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
140,899
+2,738
+2% +$2.54K 0.01% 468
2026
Q1 		$117K Buy
+138,161
New +$137K 0.01% 453

Other funds holding ONCY

DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Everhart Financial Group's ONCY Position: Q2 2026 in Review

Everhart Financial Group increased its Oncolytics Biotech (ONCY) stake by 2% in Q2 2026, buying an estimated $2.54K and bringing the position to 140,899 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #468.

Everhart Financial Group first reported a position in ONCY in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Everhart Financial Group held 140,899 shares of Oncolytics Biotech worth $134K as of Q2 2026.
  • Everhart Financial Group bought 2,738 Oncolytics Biotech shares in Q2 2026, an estimated $2.54K.
  • Oncolytics Biotech made up 0.01% of Everhart Financial Group's portfolio in Q2 2026, its #468 holding.
  • Everhart Financial Group first reported a position in Oncolytics Biotech in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.